Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab.
Lin
Ching-Yeh
CY
Chen
Hung-Chieh
HC
Hwang
Wen-Lee
WL
Teng
Chieh-Lin
CL
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D054038:Posterior Leukoencephalopathy Syndrome / Q000209:etiology* / Q000628:therapy*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000628:therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab